JP Morgan Private Wealth Advisors’s NxStage Medical Inc. NXTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-9,098
Closed -$260K – 1554
2018
Q4
$260K Hold
9,098
– – ﹤0.01% 1237
2018
Q3
$254K Hold
9,098
– – ﹤0.01% 1382
2018
Q2
$254K Hold
9,098
– – ﹤0.01% 1272
2018
Q1
$226K Hold
9,098
– – ﹤0.01% 1149
2017
Q4
$220K Hold
9,098
– – ﹤0.01% 1159
2017
Q3
$251K Sell
9,098
-430
-5% -$11.5K ﹤0.01% 1085
2017
Q2
$239K Buy
9,528
+1,430
+18% +$35.4K ﹤0.01% 1091
2017
Q1
$217K Buy
8,098
+451
+6% +$12.5K ﹤0.01% 1207
2016
Q4
$200K Sell
7,647
-4,050
-35% -$100K ﹤0.01% 1169
2016
Q3
$292K Hold
11,697
– – ﹤0.01% 997
2016
Q2
$254K Hold
11,697
– – ﹤0.01% 1050
2016
Q1
$175K Buy
+11,697
New +$196K ﹤0.01% 1106
2014
Q2
– Sell
-10,720
Closed -$137K – 937
2014
Q1
$137K Buy
+10,720
New +$140K ﹤0.01% 836

Other funds holding NXTM

JP Morgan Private Wealth Advisors's NXTM Position: Q1 2019 in Review

JP Morgan Private Wealth Advisors sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 9,098 shares — an estimated $260K sold.

JP Morgan Private Wealth Advisors first reported a position in NXTM in Q1 2014 and held it in 13 quarters. The position peaked at $292K in Q3 2016. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • JP Morgan Private Wealth Advisors reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 9,098 NxStage Medical Inc. shares in Q1 2019, an estimated $260K.
  • JP Morgan Private Wealth Advisors first reported a position in NxStage Medical Inc. in Q1 2014 and held it in 13 quarters.
  • JP Morgan Private Wealth Advisors's NxStage Medical Inc. position peaked at $292K in Q3 2016.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q1 2019, filed 30 Apr 2019.